Treated with preventive anticoagulation therapy in atrial fibrillation: The patients' perspective.
Karin Olsson, Åsa Hörnsten, Karin Hellström Ängerud
PMID 34132062WHAT IT FOUND
Patients described preventive anticoagulation as a necessary evil: it caused anxiety, lifestyle limits, and dosing burdens, but trust in nurses and doctors kept them taking it.
Key findings
01Patients described preventive anticoagulation as a necessary evil: a vital treatment weighed against unwanted consequences and risks.
02Anxiety was a major part of the experience, and most worries were felt at the beginning of treatment.
03Most participants accepted the doctor's decision rather than becoming active partners, often trusting professionals or not reflecting on the option to be involved.
STILL TO COME
How it was doneWhat they foundWhat it means for RNs
Read the rest of this summary
You get three full summaries a month, free, and we do not ask for a card. Search, the TL;DRs and your library stay unlimited either way.
What it does not show
All participants came from one Swedish university hospital and were selected from a main study of AF patients hospitalized for cardioversion, so the experiences may not represent other settings or patients who were not hospitalized. Only 15 patients were interviewed, so the themes describe a small group and do not show how common the experiences are. The study explored experiences and did not test whether nurse-led education, continuity, or shared decision-making improves adherence, bleeding, or stroke risk. Healthcare systems differ in anticoagulation monitoring and patient education, and this limits transferability to other countries.
The easy way to misread this
Do not read this as proof that a nursing education approach works. It reports patients' experiences and themes, not measured effects of any intervention.